KERRIE WILLIAMS-CODLING: Open Payments
NPI 1396591582 · SALINA, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$676 in 33 payments from 24 companies in 2025. Trend: 2023 $0 · 2024 $155 · 2025 $676
Food & beverage: $676
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 4 | $65 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $49 |
| Merck Sharp & Dohme LLC | 2 | $48 |
| AstraZeneca Pharmaceuticals LP | 2 | $47 |
| GlaxoSmithKline, LLC. | 2 | $39 |
| Incyte Corporation | 2 | $36 |
| Exelixis Inc. | 2 | $33 |
| Regeneron Healthcare Solutions, Inc. | 1 | $32 |
| Aveo Pharmaceuticals, Inc. | 1 | $28 |
| TAIHO ONCOLOGY, INC. | 1 | $27 |
Products named: KEYTRUDA, MONJUVI, DARZALEX, CABOMETYX, LIBTAYO, RYBREVANT, NINLARO, FOTIVDA.
Industry payments across KS — which companies pay providers there.
